GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioDelivery Sciences International Inc (FRA:BD5) » Definitions » Shiller PE Ratio

BioDelivery Sciences International (FRA:BD5) Shiller PE Ratio : (As of May. 28, 2024)


View and export this data going back to 2004. Start your Free Trial

What is BioDelivery Sciences International Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


BioDelivery Sciences International Shiller PE Ratio Historical Data

The historical data trend for BioDelivery Sciences International's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioDelivery Sciences International Shiller PE Ratio Chart

BioDelivery Sciences International Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioDelivery Sciences International Quarterly Data
Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioDelivery Sciences International's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, BioDelivery Sciences International's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioDelivery Sciences International's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioDelivery Sciences International's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioDelivery Sciences International's Shiller PE Ratio falls into.



BioDelivery Sciences International Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BioDelivery Sciences International's E10 for the quarter that ended in Dec. 2021 is calculated as:

For example, BioDelivery Sciences International's adjusted earnings per share data for the three months ended in Dec. 2021 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2021 (Change)*Current CPI (Dec. 2021)
=0.549/117.6295*117.6295
=0.549

Current CPI (Dec. 2021) = 117.6295.

BioDelivery Sciences International Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201203 0.174 96.783 0.211
201206 0.096 96.819 0.117
201209 -0.450 97.633 -0.542
201212 0.213 96.871 0.259
201303 -0.262 98.209 -0.314
201306 -0.265 98.518 -0.316
201309 -0.367 98.790 -0.437
201312 -0.241 98.326 -0.288
201403 -0.080 99.695 -0.094
201406 -0.103 100.560 -0.120
201409 -0.396 100.428 -0.464
201412 -0.284 99.070 -0.337
201503 -0.148 99.621 -0.175
201506 -0.330 100.684 -0.386
201509 -0.347 100.392 -0.407
201512 0.184 99.792 0.217
201603 -0.323 100.470 -0.378
201606 -0.276 101.688 -0.319
201609 -0.267 101.861 -0.308
201612 -0.275 101.863 -0.318
201703 0.813 102.862 0.930
201706 -0.240 103.349 -0.273
201709 -0.176 104.136 -0.199
201712 -0.245 104.011 -0.277
201803 -0.146 105.290 -0.163
201806 -0.137 106.317 -0.152
201809 -0.249 106.507 -0.275
201812 -0.070 105.998 -0.078
201903 -0.044 107.251 -0.048
201906 -0.115 108.070 -0.125
201909 0.003 108.329 0.003
201912 0.000 108.420 0.000
202003 0.045 108.902 0.049
202006 0.009 108.767 0.010
202009 0.076 109.815 0.081
202012 0.082 109.897 0.088
202103 0.042 111.754 0.044
202106 0.075 114.631 0.077
202109 0.060 115.734 0.061
202112 0.549 117.630 0.549

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


BioDelivery Sciences International  (FRA:BD5) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


BioDelivery Sciences International Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of BioDelivery Sciences International's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BioDelivery Sciences International (FRA:BD5) Business Description

Traded in Other Exchanges
N/A
Address
4131 ParkLake Avenue, Suite 225, Raleigh, NC, USA, 27612
BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

BioDelivery Sciences International (FRA:BD5) Headlines

No Headlines